Monday , February 20 2017
Home / Resources / Videos

Videos

We have videos from AACE, ADA, and AADE that feature the speakers from those events. You will be the first to learn about the breakthroughs in diabetes care. You will also hear about interesting research projects that our featured diabetes experts are leading.

Bernstein’s Diabetes University Videos on YouTube

bernstein-small

Bernstein’s Diabetes University Videos on YouTube  Our Advisory Board member, Dr. Richard K. Bernstein, has recently created, “Dr. Bernstein’s Diabetes University,” a complete course of video classes geared towards patients, which is now available on Youtube. Dr. Bernstein’s Diabetes University Playlist includes these short videos: “Basic Science of Diabetes,” “Values ...

Read More »

Christophe Arbet-Engels, MD, Q1: Empagliflozin Studies Results

Dr. Christophe Arbet-Engels, discusses some of the study results on empagliflozin in which more than 14,000 patients were involved in several different study configurations including monotherapy, empagliflozin as an add-on, and patients with renal impairment.   Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer ...

Read More »

Christophe Arbet-Engels, MD, Q10: Possibility of Combination Drugs with Empagliflozin

Dr. Christophe Arbet-Engels continues his discussion of the potential for combining the SGLT-2 inhibitor empagliflozin with other drugs down the road, and that they will certainly be exploring these otpions.  Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc. See more SGLT-2 Resources

Read More »

Christophe Arbet-Engels, MD, Q11: Is Empagliflozin Also Being Submitted Internationally?

Dr. Christophe Arbet-Engels explains that Boehringer Ingelheim will also be submitting empagliflozin internationally, and certainly in the EU, and that they will also look carefully at all possibilities to submit the drug to other international authorities. Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim ...

Read More »